[1]袁建伟,杨劼,贺小红,等.18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值[J].国际放射医学核医学杂志,2013,37(4):199-202.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
　YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Diagnosis value of 18F-FDG PET/CT and 3.0T MRI combined imaging in detecting the primary focus of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):199-202.[doi:10.3760/cma.j.issn.1673-4114.2013.04.003]
点击复制

18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
37
期数:
2013年第4期
页码:
199-202
栏目:
论著
出版日期:
2013-07-25

文章信息/Info

Title:
Diagnosis value of 18F-FDG PET/CT and 3.0T MRI combined imaging in detecting the primary focus of breast cancer
作者:
袁建伟1;  杨劼2;  贺小红3;  张培培4;  肖菊梅1;  王颖1
1. 528000 佛山, 佛山市第一人民医院核医学科;
2. 528000 佛山, 佛山市第一人民医院胸外科;
3. 528000 佛山, 佛山市第一人民医院影像科;
4. 528000 佛山, 佛山市第一人民医院神经外科
Author(s):
YUAN Jian-wei1;  YANG Jie2;  HE Xiao-hong3;  ZHANG Pei-pei4;  XIAO Ju-mei1;  WANG Ying1
Department of Nuclear Medicine, the First People’ Hospital of Foshan, Foshan 528000, China
关键词:
乳腺肿瘤; 正电子发射断层显像术; 体层摄影术; X线计算机; 氟脱氧葡萄糖F18; 磁共振成像
Keywords:
Breast neoplasms; Positron-emission tomography; Tomography; X-ray computed; Fluorodeoxyglucose F18; Magnetic resonance imaging; Magnetic resonance imaging
DOI:
10.3760/cma.j.issn.1673-4114.2013.04.003
摘要:
目的 探讨18F-FDG PET/CT与3.0T MRI联合显像在乳腺癌原发病灶诊断中的价值。方法 对38例临床怀疑为乳腺癌的女性患者于一周内分别行18F-FDG PET/CT、3.0T MRI和病理学检查。结果 组织病理学检查结果证实,全部患者中,24例为乳腺癌患者,14例为乳腺良性肿瘤患者。3.0T MRI诊断乳腺癌的灵敏度、特异度、准确率分别为91.7%、78.6%、86.8%;PET/CT诊断乳腺癌的灵敏度、特异度、准确率分别为87.5%、92.9%、89.5%;PET/CT和3.0T MR联合显像诊断乳腺癌的灵敏度、特异度、准确率分别为100.0%、92.9%、97.4%;3种显像方法间灵敏度、特异度、准确率差异无统计学意义(χ2=2.987、1.612和2.955,P均>0.05)。结论 18F-FDG PET/CT和3.0T MRI联合显像在乳腺癌原发病灶诊断中具有重要价值;但与单独18F-FDG PET/CT和3.0T MRI显像比较,3种显像方法在乳腺癌原发病灶的诊断效能上差异无统计学意义。
Abstract:
Objective To explore the diagnosis value of 18F-FDG PET/CT and 3.0T MR combined imaging in detecting the primary focus of breast cancer.Methods Thirty eight female patients with highly suspected breast cancer were selected,18F-FDG PET/CT and 3.0T MRI imaging were performed and their pathological results were gotten within 7 days.Results Twenty four malignant cases and 14 benign cases of the 38 patients were proved by pathology.The sensitivity,specificity and accuracy rate obtained by 3.0T MRI were 91.7%,78.6% and 86.8%,respectively; they were 87.5%,92.9% and 89.5% for 18F-FDG PET/CT; and which were 100.0%,92.9% and 97.4% with 18F-FDG PET/CT and 3.0T MRI combined imaging.There were no significant difference among the three methods in the diagnostic ability (χ2=2.987,1.612 and 2.955,all P>0.05).Conclusions The combination of 18F-FDG PET/CT imaging and 3.0T MRI imaging in detecting the primary focus of breast cancer has important value,and comparison with separate 18F-FDG PET/CT imaging or 3.0T MRI imaging,the diagnosis efficiency of three imaging methods in breast cancer without statistics difference.

参考文献/References:

[1] 余丰文,冯彦林,贺小红,等. PET-CT与钼靶X线、B超定性诊断乳腺癌的临床对比研究. 国际放射医学核医学杂志,2006,30(3):148-151.
[2] Wang Y, Yu J, Liu J, et al. PET-CT in the diagnosis of both primary breast cancer and axillary lymph node metastasis:initial experience. Int J Radiat Oncol Biol phys, 2003,57(2 Suppl):S362-363.
[3] Scheidhauer K, Walter C, Seemann MD. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. Eur J Nucl Med Mol Imaging, 2004, 31(1 Suppl):S70-79.
[4] 赵桐,王永胜,杨国仁,等. PET/CT在乳腺癌保乳微创治疗中的应用研究. 肿瘤研究与临床,2004,16(2):103-106.
[5] 赵继红,丁军,徐松柏,等18F-FDG PET/CT与MRI对乳腺癌诊断价值的比较. 吉林大学学报:医学版,2011,37(4):746-749.
[6] 唐立岷,马超. 18F-FDG PET/CT在诊断浸润性乳腺癌和淋巴结转移中的价值. 上海交通大学学报:医学版,2012,32(6):761-765.
[7] Walter C, Scheidhauer K, Scharl A, et al. Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions. Eur Radiol, 2003, 13(7):1651-1656.
[8] Wahl RL, Siegel BA, Coleman RE, et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:a report of the staging breast cancer with PET Study Group. J Clin Oncol, 2004, 22(2):277-285.
[9] 易梅,程绍玲,李冬梅. 钼靶、MRI在乳腺癌诊断中的应用. 中国医药导报,2008,5(8):87.
[10] Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging:features and positive predictive value. AJR Am J Roentgenol, 2002, 179(1):171-178.
[11] Al-Khawari H, Kovacs A, Athyal R, et al. Breast magnetic resonance imaging:initial experience in Kuwait. Med Princ Pract,2009,18(2):143-148.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
　Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
　Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
　Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
　Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
　Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
　Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[9]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
　Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[10]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[11]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
　Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[12]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
　Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[13]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
　Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[14]董佳佳,章斌.多种影像学方法评价乳腺癌新辅助化疗疗效的价值比较[J].国际放射医学核医学杂志,2014,38(6):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
　Dong Jia-jia,Zhang Bin.Comparision on the values of different image modalities in monitoring the response to neoadjuvant chemotherapy in breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):427.[doi:10.3760/cma.j.issn.1673-4114.2014.06.018]
[15]袁建伟,杨劼,贺小红,等.乳腺癌18F-FDG PET/CT和3.0T MRI联合显像评分与Ki-67表达水平的相关性分析[J].国际放射医学核医学杂志,2013,37(2):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
　YUAN Jian-wei,YANG Jie,HE Xiao-hong,et al.Correlation between combined imaging modalities of 18F-FDG PET/CT and 3.0T MRI and expression of Ki-67 in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):84.[doi:10.3760/cma.j.issn.1673-4114.2013.02.006]
[16]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
　LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[17]夏晓天,张永学.影像学检查在乳腺癌的诊断及疗效评估中的应用价值[J].国际放射医学核医学杂志,2010,34(4):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
　XIA Xiao-tian,ZHANG Yong-xue.The value of imaging examinations in diagnosis and curative effect evaluation of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):242.[doi:10.3760/cma.j.issn.1673-4114.2010.04.014]
[18]鲁胜男,冯彦林.乳腺癌新辅助化疗过程中18F-FDG PET-CT与化疗前Ki-67、COX-2表达的相关性研究[J].国际放射医学核医学杂志,2011,35(4):238.[doi:10.3760/cma.j.issn.1673-4114.2011.04.011]
　LU Sheng-nan,FENG Yan-lin.The correlation analysis between 18F-FDG PET-CT in breast cancer with neoadjuvant chemotherapy and the expression of Ki-67 and COX-2 before neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):238.[doi:10.3760/cma.j.issn.1673-4114.2011.04.011]
[19]张亶,章斌,邓胜明,等.18F-FDG PET/CT在乳腺癌术后随访中的价值[J].国际放射医学核医学杂志,2017,41(3):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]
　Zhang Dan,Zhang Bin,Deng Shengming,et al.Clinical value of 18F-FDG PET/CT in follow-up of postoperative breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(4):159.[doi:10.3760/cma.j.issn.1673-4114.2017.03.001]

备注/Memo

备注/Memo:
收稿日期:2012-11-08。
基金项目:佛山市医学类科技攻关项目(200908066);佛山市卫生局科研项目(2010056)
通讯作者:袁建伟,Email:yjwei214@hotmail.com
更新日期/Last Update: 1900-01-01